Commonwealth Financial Services LLC Decreases Stock Position in The Clorox Company (NYSE:CLX)

Commonwealth Financial Services LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX) by 9.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,912 shares of the company’s stock after selling 197 shares during the quarter. Commonwealth Financial Services LLC’s holdings in Clorox were worth $254,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of CLX. Core Wealth Advisors Inc. acquired a new position in shares of Clorox during the fourth quarter worth about $29,000. Innealta Capital LLC purchased a new position in Clorox in the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. GoalVest Advisory LLC purchased a new stake in shares of Clorox in the 1st quarter valued at approximately $31,000. Finally, First Foundation Advisors acquired a new stake in shares of Clorox in the 1st quarter valued at $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.8 %

CLX opened at $163.33 on Monday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The business has a 50 day moving average price of $149.14 and a two-hundred day moving average price of $143.69. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The company has a market cap of $20.28 billion, a PE ratio of 84.63, a P/E/G ratio of 3.29 and a beta of 0.40.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. As a group, research analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Analyst Ratings Changes

Several equities analysts recently commented on CLX shares. Argus raised Clorox to a “hold” rating in a report on Tuesday, June 4th. Barclays upped their price objective on Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. DA Davidson reissued a “neutral” rating and set a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six investment analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $143.33.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.51% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.